Tandem Diabetes Care
TNDM
279 hedge funds and large institutions have $3.6B invested in Tandem Diabetes Care in 2020 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 80 increasing their positions, 106 reducing their positions, and 55 closing their positions.
11% more capital invested
Capital invested by funds: $3.24B → $3.6B (+$358M)
1.75% more ownership
Funds ownership: 92.03% → 93.78% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
2% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 55
2% less call options, than puts
Call options by funds: $35.8M | Put options by funds: $36.6M
2% less funds holding
Funds holding: 284 → 279 (-5)
25% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 106
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$262M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$226M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$61.2M |
| 4 |
RI
RTW Investments
New York
|
+$31.1M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$20.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$68M |
| 2 |
DM
Deerfield Management
New York
|
-$66.5M |
| 3 |
FAM
Fred Alger Management
New York
|
-$34.9M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$32.8M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$29.7M |
TNDM Hedge Fund Activity: Q1 2020 in Review
279 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2020, worth a combined $3.6B — up 11% from $3.24B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of TNDM and 54 opened new positions — a net loss of 1 holder — while 106 trimmed existing stakes and 80 added.
The largest buyer was Wellington Management Group, adding an estimated $262M. The largest seller was OrbiMed, exiting entirely with an estimated $68M sold.
- 279 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2020, down from 284 in Q4 2019.
- Funds reported $3.6B of Tandem Diabetes Care stock for Q1 2020, up 11% quarter-over-quarter.
- 54 funds opened new Tandem Diabetes Care positions in Q1 2020 and 55 closed out, a net change of -1 holder.
- The largest Tandem Diabetes Care buyer in Q1 2020 was Wellington Management Group, an estimated $262M added.
- The largest Tandem Diabetes Care seller in Q1 2020 was OrbiMed, an estimated $68M sold.
Based on aggregated 13F filings for Q1 2020.